Sign up to save your podcasts
Or
Share JPMorgan’s Sharp Reversal… And The Latest Entry To The Weight Loss Drug Battle 5/20/24
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
JPMorgan’s Sharp Reversal… And The Latest Entry To The Weight Loss Drug Battle 5/20/24
Shares of JPMorgan losing steam in the session after CEO Jamie Dimon’s comments on owning the bank, and his own succession plans. Where the financial heavyweight is heading next. Plus Telehealth provider Hims & Hers surging after announcing it will offer GLP-1 injections. How they’re hoping to tip the scales in the obesity drug wars.
Fast Money Disclaimer
View all episodes
By CNBC
3.9
12371,237 ratings
Shares of JPMorgan losing steam in the session after CEO Jamie Dimon’s comments on owning the bank, and his own succession plans. Where the financial heavyweight is heading next. Plus Telehealth provider Hims & Hers surging after announcing it will offer GLP-1 injections. How they’re hoping to tip the scales in the obesity drug wars.
Fast Money Disclaimer
More shows like CNBC's "Fast Money"
View all
Mad Money w/ Jim Cramer
4,081 Listeners
Investing Insights
496 Listeners
CNBC's "Options Action"
238 Listeners
Motley Fool Money
3,179 Listeners
Your Money Minute
147 Listeners
The Exchange
327 Listeners
Fortt Knox
67 Listeners
Strange Success with Jane Wells
153 Listeners
American Greed Podcast
2,130 Listeners
The Compound and Friends
2,075 Listeners
Squawk on the Street
601 Listeners
Squawk Pod
545 Listeners
The Keynote by CNBC Events
20 Listeners
Barron's Live
200 Listeners
Halftime Report
408 Listeners
CNBC's "Last Call"
302 Listeners
Worldwide Exchange
115 Listeners
RiskReversal Pod
807 Listeners
MRKT Matrix
181 Listeners
TechCheck
60 Listeners
Closing Bell
156 Listeners
Power Lunch
22 Listeners
Manifest Space with Morgan Brennan
34 Listeners
CNBC’s “Money Movers”
16 Listeners
CNBC Business News Update
9 Listeners
The Crimes of Putin’s Trader
276 Listeners
CNBC Sport
15 Listeners